Q32 Bio Inc. (QTTB) Current Assets (2017 - 2026)

Q32 Bio has reported Current Assets for 10 years, with the latest figure at $109.6 million in Q2 2026.

• On a quarterly basis, Current Assets rose 87.99% year-over-year to $109.6 million in Q2 2026; TTM through Jun 2026 was $109.6 million, a 87.99% increase from a year earlier, with the FY2025 full-year figure at $55.0 million, down 32.77% from the prior year.
• Current Assets was $109.6 million for Q2 2026 at Q32 Bio, up from $57.2 million in the prior quarter.
• The five-year high for Current Assets was $262.4 million in Q1 2022, with the low at $28.7 million in Q4 2023.
• Average Current Assets over 5 years is $118.9 million, with a median of $108.1 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Current Assets tumbled 84.14% in 2023, then jumped 185.13% in 2024.
• Over 5 years, Current Assets stood at $181.0 million in 2022, then sank by 84.14% to $28.7 million in 2023, then surged by 185.13% to $81.9 million in 2024, then sank by 32.77% to $55.0 million in 2025, then soared by 99.18% to $109.6 million in 2026.
• The last three Current Assets figures came in at $109.6 million (Q2 2026), $57.2 million (Q1 2026), and $55.0 million (Q4 2025), per Business Quant data.